View Older Stories View More Recent Stories

Feb 8, 2021 08:00AM Monte Rosa Therapeutics Expands Senior Management Team
Feb 8, 2021 07:07AM Gemini Therapeutics (GMTX) Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
Feb 8, 2021 07:00AM Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
Feb 3, 2021 05:21PM Form SC 13G F-star Therapeutics, Filed by: Atlas Venture Fund VII L P
Feb 3, 2021 05:14PM Form SC 13G F-star Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 3, 2021 03:50PM Form 13F-HR Atlas Venture Associates For: Dec 31
Feb 2, 2021 01:05PM Form SC 13G/A Larimar Therapeutics, Filed by: Atlas Venture Fund VII L P
Feb 2, 2021 01:03PM Form SC 13G/A Spero Therapeutics, Inc. Filed by: Atlas Venture Fund IX, L.P.
Feb 2, 2021 01:03PM Form SC 13G/A Surface Oncology, Inc. Filed by: Atlas Venture Fund IX, L.P.
Feb 2, 2021 01:02PM Form SC 13G/A Cogent Biosciences, Inc. Filed by: Atlas Venture Fund IX, L.P.
Feb 2, 2021 01:01PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Atlas Venture Fund VIII, L.P.
Feb 2, 2021 01:01PM Form SC 13G/A Translate Bio, Inc. Filed by: Atlas Venture Fund VIII, L.P.
Feb 1, 2021 02:40PM Form 13F-HR Atlas Venture Associates For: Dec 31
Feb 1, 2021 02:40PM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 1, 2021 02:39PM Form 13F-NT ATLAS VENTURE FUND VI For: Dec 31
Feb 1, 2021 02:38PM Form 13F-NT Atlas Venture Associates For: Dec 31
Jan 25, 2021 08:00AM Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction
Jan 25, 2021 08:00AM Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction
Jan 7, 2021 07:00AM Korro Bio to Present at J.P. Morgan Healthcare Conference
Jan 7, 2021 07:00AM Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
Jan 5, 2021 11:24AM MPM Capital Announces the Promotions of Shinichiro Fuse, Ph.D. and Kristen Laguerre to its Investment Committee
Jan 5, 2021 07:00AM Ikena Oncology Closes $120 Million Series B Financing Led by Omega Funds
Dec 28, 2020 07:40AM Form SC 13D Skillz Inc. Filed by: Atlas Venture Fund IX, L.P.
Dec 22, 2020 07:00AM Q32 Bio Appoints Experienced Biopharmaceutical Leader Mark Iwicki as Chairman of Board of Directors
Dec 21, 2020 03:35PM Form 4/A Surface Oncology, Inc. For: Dec 17 Filed by: Atlas Venture Associates IX, L.P.
Dec 21, 2020 01:33PM Form 4 Surface Oncology, Inc. For: Dec 17 Filed by: Atlas Venture Associates IX, L.P.
Dec 17, 2020 06:20PM Form 4 Generation Bio Co. For: Dec 15 Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 17, 2020 04:15PM Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%
Dec 17, 2020 01:15AM Cadent Therapeutics Enters Agreement to be Acquired by Novartis
Dec 8, 2020 08:00AM Vigil Neuroscience Launches with $50 Million in Financing to Develop Microglia-based Therapeutics for Neurodegenerative Diseases
Dec 8, 2020 06:00AM Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
Nov 30, 2020 07:00AM Kinaset Therapeutics Launches with a $40M Series A Financing to Develop Novel Therapeutics for Respiratory Diseases and an Exclusive Global License Agreement with Vectura Group for KN-002 (VR588), a N
Nov 19, 2020 11:00AM Day One Announces Preliminary Phase 1 Results for DAY101 in Pediatric Low-Grade Glioma, Receipt of Breakthrough Therapy Designation (BTD) and New Phase 2 Study
Nov 19, 2020 09:36AM The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
Nov 19, 2020 09:17AM The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
Nov 19, 2020 09:17AM The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
Nov 19, 2020 07:00AM Ikena Oncology Assembles Multi-Disciplinary Scientific Advisory Board
Nov 16, 2020 07:00AM Atlas Venture Welcomes Rajesh Devraj, PhD, as Venture Partner
Nov 12, 2020 07:13AM Form 13F-HR Atlas Venture Advisors, For: Sep 30
Nov 12, 2020 07:13AM Form 13F-HR Atlas Venture Associates For: Sep 30
Nov 12, 2020 07:13AM Form 13F-NT Atlas Venture Associates For: Sep 30
Nov 12, 2020 07:13AM Form 13F-NT Atlas Venture Associates For: Sep 30
Nov 12, 2020 07:13AM Form 13F-NT ATLAS VENTURE FUND VI For: Sep 30
Nov 10, 2020 07:00AM Korro Bio Appoints Ram Aiyar, Ph.D., MBA, as Chief Executive Officer
Nov 9, 2020 08:02AM Ikena Oncology to Present New Preclinical Data on AHR Antagonist IK-175 at the Society for Immunotherapy of Cancer’s 2020 Annual Meeting
Oct 29, 2020 07:00AM Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Oct 29, 2020 02:15AM Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
Oct 28, 2020 05:20AM Digital therapeutics leader Sidekick raises $20M in Series A funding round led by Wellington and Asabys
Oct 26, 2020 06:00AM Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0
Oct 22, 2020 07:00AM Be Biopharma Launches with $52 Million Series A Financing to Advance B Cells as Medicines
View More Recent Stories View Older Stories